Joel A Sincavage

Array ( [id] => 7138072 [patent_doc_number] => 20050182015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Antisense modulation of EIF2C1 expression' [patent_app_type] => utility [patent_app_number] => 11/035669 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25837 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182015.pdf [firstpage_image] =>[orig_patent_app_number] => 11035669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050707 [patent_doc_number] => 20050186594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Compositions and their uses directed to cell growth and maintenance proteins' [patent_app_type] => utility [patent_app_number] => 11/015161 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38007 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186594.pdf [firstpage_image] =>[orig_patent_app_number] => 11015161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983855 [patent_doc_number] => 20050153925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Compositions and their uses directed to transferases' [patent_app_type] => utility [patent_app_number] => 11/013608 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21842 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153925.pdf [firstpage_image] =>[orig_patent_app_number] => 11013608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7503568 [patent_doc_number] => 08034789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Antisense compounds targeted to connexins and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/581813 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 38789 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034789.pdf [firstpage_image] =>[orig_patent_app_number] => 10581813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040469 [patent_doc_number] => 20050159384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Human RNase III and compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/001993 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13031 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159384.pdf [firstpage_image] =>[orig_patent_app_number] => 11001993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404698 [patent_doc_number] => 07288530 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Antisense modulation of survivin expression' [patent_app_type] => utility [patent_app_number] => 10/983392 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20298 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288530.pdf [firstpage_image] =>[orig_patent_app_number] => 10983392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446386 [patent_doc_number] => 08288439 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Methods and compositions for the inhibition of HIV-1 replication' [patent_app_type] => utility [patent_app_number] => 10/578536 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 30 [patent_no_of_words] => 24847 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10578536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823092 [patent_doc_number] => 20080227733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Method for Treating and Preventing Ischemia-Reperfusion Injury Using Rna Interfering Agent' [patent_app_type] => utility [patent_app_number] => 10/577814 [patent_app_country] => US [patent_app_date] => 2004-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23754 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227733.pdf [firstpage_image] =>[orig_patent_app_number] => 10577814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105122 [patent_doc_number] => 20050107328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Antisense modulation of polo-like kinase expression' [patent_app_type] => utility [patent_app_number] => 10/974931 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30313 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107328.pdf [firstpage_image] =>[orig_patent_app_number] => 10974931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105121 [patent_doc_number] => 20050107327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Method for reducing overproduction of neuropeptide Y in an individual' [patent_app_type] => utility [patent_app_number] => 10/969918 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8179 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107327.pdf [firstpage_image] =>[orig_patent_app_number] => 10969918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085836 [patent_doc_number] => 20070275887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Method of Inhibiting Secretase Activity' [patent_app_type] => utility [patent_app_number] => 10/576281 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6717 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275887.pdf [firstpage_image] =>[orig_patent_app_number] => 10576281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944962 [patent_doc_number] => 20110105582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Composition for inhibiting function of human flt3' [patent_app_type] => utility [patent_app_number] => 10/574904 [patent_app_country] => US [patent_app_date] => 2004-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15433 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105582.pdf [firstpage_image] =>[orig_patent_app_number] => 10574904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 62932 [patent_doc_number] => 07763580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Methods for treating conditions associated with the accumulation of excess extracellular matrix' [patent_app_type] => utility [patent_app_number] => 10/952361 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 34 [patent_no_of_words] => 19467 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763580.pdf [firstpage_image] =>[orig_patent_app_number] => 10952361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127885 [patent_doc_number] => 20050059629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Antisense modulation of connective tissue growth factor expression' [patent_app_type] => utility [patent_app_number] => 10/946914 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33143 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059629.pdf [firstpage_image] =>[orig_patent_app_number] => 10946914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 800400 [patent_doc_number] => 07425544 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'Modulation of eIF4E expression' [patent_app_type] => utility [patent_app_number] => 10/571339 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52001 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425544.pdf [firstpage_image] =>[orig_patent_app_number] => 10571339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256245 [patent_doc_number] => 07575918 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Tissue-specific and pathogen-specific ribozymes' [patent_app_type] => utility [patent_app_number] => 10/935962 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 39 [patent_no_of_words] => 34069 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/575/07575918.pdf [firstpage_image] =>[orig_patent_app_number] => 10935962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983846 [patent_doc_number] => 20050153916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/923330 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 68766 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153916.pdf [firstpage_image] =>[orig_patent_app_number] => 10923330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966447 [patent_doc_number] => 20050233344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/923270 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 68277 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233344.pdf [firstpage_image] =>[orig_patent_app_number] => 10923270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952840 [patent_doc_number] => 20050227935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/923470 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 66064 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227935.pdf [firstpage_image] =>[orig_patent_app_number] => 10923470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7184342 [patent_doc_number] => 20050191618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/923473 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 69795 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191618.pdf [firstpage_image] =>[orig_patent_app_number] => 10923473 [rel_patent_id] =>[rel_patent_doc_number] =>)